These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 38255695)

  • 1. Anti-Cryptosporidial Drug-Discovery Challenges and Existing Therapeutic Avenues: A "One-Health" Concern.
    Ali M; Xu C; Nawaz S; Ahmed AE; Hina Q; Li K
    Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38255695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: A comprehensive review.
    Khan SM; Witola WH
    Front Cell Infect Microbiol; 2023; 13():1115522. PubMed ID: 36761902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine Kinase Inhibitors Display Potent Activity against Cryptosporidium parvum.
    Nava MG; Calderón F; Fernández E; Ballell L; Bamborough P; Vinayak S
    Microbiol Spectr; 2023 Feb; 11(1):e0387422. PubMed ID: 36533912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocompetent rabbits infected with Cryptosporidium cuniculus as an animal model for anti-cryptosporidial drug testing.
    Lu C; Liu X; Liu J; Tang X; Zhu G; Striepen B; Suo X
    Int J Parasitol; 2022 Mar; 52(4):205-210. PubMed ID: 34774541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Anti-cryptosporidial Activities From Natural Products by
    Jin Z; Ma J; Zhu G; Zhang H
    Front Microbiol; 2019; 10():1999. PubMed ID: 31551955
    [No Abstract]   [Full Text] [Related]  

  • 6. Host cells with transient overexpression of MDR1 as a novel in vitro model for evaluating on-target effect for activity against the epicellular Cryptosporidium parasite.
    Yang B; Wang D; Liu M; Wu X; Yin J; Zhu G
    J Antimicrob Chemother; 2021 Dec; 77(1):124-134. PubMed ID: 34648615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herbal-based compounds: A review on treatments of cryptosporidiosis.
    Namazi F; Razavi SM
    Int J Parasitol Drugs Drug Resist; 2024 Apr; 24():100521. PubMed ID: 38246099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptosporidial infection in children with inflammatory bowel disease.
    Vadlamudi N; Maclin J; Dimmitt RA; Thame KA
    J Crohns Colitis; 2013 Oct; 7(9):e337-43. PubMed ID: 23415795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On-target inhibition of Cryptosporidium parvum by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel MDR1-transgenic host cell model and algorithms to quantify the effect on the parasite target.
    Yang B; Yan Y; Wang D; Zhang Y; Yin J; Zhu G
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011217. PubMed ID: 36972284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octaarginine Improves the Efficacy of Nitazoxanide against
    Nguyen-Ho-Bao T; Ambe LA; Berberich M; Hermosilla C; Taubert A; Daugschies A; Kamena F
    Pathogens; 2022 Jun; 11(6):. PubMed ID: 35745507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
    Manjunatha UH; Chao AT; Leong FJ; Diagana TT
    ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Khan SM; Zhang X; Witola WH
    Front Microbiol; 2021; 12():800293. PubMed ID: 35046922
    [No Abstract]   [Full Text] [Related]  

  • 13. Garlic (Allium sativum Linnaeus) improved inflammation and reduced cryptosporidiosis burden in immunocompromised mice.
    Farid A; Yousry M; Safwat G
    J Ethnopharmacol; 2022 Jun; 292():115174. PubMed ID: 35259443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of inhibitors for two glycolytic enzymes portrays high synergistic efficacy against
    Khan SM; Bajwa MR; Lahar RY; Witola WH
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0056923. PubMed ID: 37655889
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of clofazimine and nitazoxanide combination in treating intestinal cryptosporidiosis and enhancing intestinal cellular regeneration in immunocompromised mice.
    Esmat M; Abdel-Aal AA; Shalaby MA; Badawi M; Elaskary H; Yousif AB; Fahmy MA
    Food Waterborne Parasitol; 2022 Jun; 27():e00161. PubMed ID: 35601881
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of potent anti-Cryptosporidium new drug leads by screening traditional Chinese medicines.
    Kabir MHB; Recuenco FC; Mohd Zin NK; Watanabe N; Fukuda Y; Bando H; Watanabe K; Bochimoto H; Xuan X; Kato K
    PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010947. PubMed ID: 36441814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cryptosporidial drug activity screened with an immunosuppressed rat model.
    Brasseur P; Lemeteil D; Ballet JJ
    J Protozool; 1991; 38(6):230S-231S. PubMed ID: 1818183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of cryptosporidiosis: an update review.
    Abd-Ella OH
    J Egypt Soc Parasitol; 2014 Aug; 44(2):455-66. PubMed ID: 25597160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of respiratory Cryptosporidiosis: evidence for transmission by inhalation.
    Sponseller JK; Griffiths JK; Tzipori S
    Clin Microbiol Rev; 2014 Jul; 27(3):575-86. PubMed ID: 24982322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.